First Turn Management »

Oric Pharmaceuticals shares owned by First Turn Management

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $15M 1.1M 13.75

More positions owned by First Turn Management

Shockwave Med (SWAV)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Xenon Pharmaceuticals (XENE)
Sarepta Therapeutics (SRPT)
Axsome Therapeutics (AXSM)
Dex (DXCM)
Immunocore Hldgs Ads (IMCR)
Apogee Therapeutics (APGE)
Vertex Pharmaceuticals Incorporated (VRTX)
Mirum Pharmaceuticals (MIRM)
Biohaven (BHVN)
Krystal Biotech (KRYS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Transmedics Group (TMDX)

View all positions for First Turn Management

Top funds holding Oric Pharmaceuticals

Nextech Invest
FMR
VR Adviser
Frazier Life Sciences Management
Viking Global Investors
Column Group
EcoR1 Capital
BlackRock
Vanguard Group
Commodore Capital
Boxer Capital
T. Rowe Price Associates
Arrowpoint Asset Management
NEA Management Company
First Turn Management

View all funds holding Oric Pharmaceuticals